Bentley

About Bentley

Bentley’s passion is the development, manufacturing and marketing of innovative implants for minimal-invasive treatments of vascular diseases. Bentley was founded in 2009 by medical entrepreneurs Lars Sunnanväder and Miko Obradovic. The company has seen substantial growth since the launch of its first product in 2012. Since then Bentley rapidly expanded worldwide. Thanks to its international network of exclusive distribution partners Bentley is represented in more than 80 countries – in some even as market leader. Bentley is the only company worldwide that offers a covered balloon expandable stent to cardiologists, (endo-)vascular surgeons and interventional radiologists in a size range from 2.5 mm to 30 mm in diameter. The ten top-line products in Bentley’s portfolio are: BeGraft coronary (2012), BeGraft peripheral: first generation (2013); second generation (2015), BeSmooth peripheral (2014), BeGraft aortic (2016), BeGraft peripheral PLUS (2017), BeYond venous (2020), BeBack crossing catheter (2023), BeGraft (2025), BeFlow iliac (2025), BeFlared FEVAR (2025).